HUP9901355A3 - For using amino acids and - compounds for additives of x-ray contrast matter solucions, and making drugs and diagnostics - Google Patents

For using amino acids and - compounds for additives of x-ray contrast matter solucions, and making drugs and diagnostics

Info

Publication number
HUP9901355A3
HUP9901355A3 HU9901355A HUP9901355A HUP9901355A3 HU P9901355 A3 HUP9901355 A3 HU P9901355A3 HU 9901355 A HU9901355 A HU 9901355A HU P9901355 A HUP9901355 A HU P9901355A HU P9901355 A3 HUP9901355 A3 HU P9901355A3
Authority
HU
Hungary
Prior art keywords
solucions
diagnostics
additives
compounds
amino acids
Prior art date
Application number
HU9901355A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HUP9901355A2 publication Critical patent/HUP9901355A2/hu
Publication of HUP9901355A3 publication Critical patent/HUP9901355A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9901355A 1996-01-25 1997-01-27 For using amino acids and - compounds for additives of x-ray contrast matter solucions, and making drugs and diagnostics HUP9901355A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19604095 1996-01-25

Publications (2)

Publication Number Publication Date
HUP9901355A2 HUP9901355A2 (hu) 1999-08-30
HUP9901355A3 true HUP9901355A3 (en) 2000-06-28

Family

ID=7784538

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901355A HUP9901355A3 (en) 1996-01-25 1997-01-27 For using amino acids and - compounds for additives of x-ray contrast matter solucions, and making drugs and diagnostics

Country Status (21)

Country Link
US (1) US6638913B1 (hu)
EP (1) EP0876140B1 (hu)
JP (1) JP2000505789A (hu)
KR (1) KR100505772B1 (hu)
CN (1) CN1209751A (hu)
AT (1) ATE251893T1 (hu)
AU (1) AU2150497A (hu)
BG (1) BG62913B1 (hu)
BR (1) BR9707081A (hu)
CA (1) CA2244209C (hu)
CZ (1) CZ234898A3 (hu)
DE (2) DE19703816A1 (hu)
DK (1) DK0876140T3 (hu)
ES (1) ES2208884T3 (hu)
HU (1) HUP9901355A3 (hu)
IL (1) IL124676A0 (hu)
NO (1) NO983438L (hu)
PL (1) PL328199A1 (hu)
PT (1) PT876140E (hu)
SK (1) SK101398A3 (hu)
WO (1) WO1997026862A2 (hu)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
AU1297899A (en) 1997-10-31 1999-05-24 Walter Reed Army Institute Of Research Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
RU2252933C2 (ru) 1998-04-01 2005-05-27 Кардиом Фарма Корп. Простые эфиры аминоциклогексанола, композиция, обладающая антиаритмической активностью (варианты), и их применение
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
IL155002A0 (en) 2000-10-12 2003-10-31 Genentech Inc Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20020169112A1 (en) * 2001-05-08 2002-11-14 Luc Montagnier Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
BRPI0318278B8 (pt) 2003-05-02 2024-01-09 Cardiome Pharma Corp Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
WO2005097087A2 (en) 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
EP1729815A2 (en) 2004-04-01 2006-12-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
MX2007005496A (es) 2004-11-08 2007-07-09 Cardiome Pharma Corp Nuevo regimen de dosificacion para compuestos moduladores de canal de iones, para el tratamiento de fibrilacion auricular aguda en un humano.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
EP1897535A1 (en) * 2006-08-30 2008-03-12 Dirinco AG Substitution fluid for haemofiltration
US20090239894A1 (en) * 2008-03-20 2009-09-24 Bjorn Schurad Stabilized aqueous solutions of ergoline compounds
CA2754528A1 (en) 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation
US10634741B2 (en) 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
US9427186B2 (en) * 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
NZ602115A (en) 2010-03-01 2014-12-24 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
CN102319258B (zh) * 2011-08-04 2012-10-31 山西诺成制药有限公司 一种5%葡萄糖置换液及其制备方法
US9592297B2 (en) 2012-08-31 2017-03-14 Bayer Healthcare Llc Antibody and protein formulations
US8613919B1 (en) 2012-08-31 2013-12-24 Bayer Healthcare, Llc High concentration antibody and protein formulations
WO2014140543A1 (en) 2013-03-11 2014-09-18 Endomagnetics Ltd. Hypoosmotic solutions for lymph node detection
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
CN105579069A (zh) * 2013-03-27 2016-05-11 通用电气医疗集团股份有限公司 用于制备诊断组合物的方法和试剂
ES2833377T3 (es) 2015-06-04 2021-06-15 Endomagnetics Ltd Materiales marcadores y formas de localizar un marcador magnético
WO2019201904A1 (en) * 2018-04-16 2019-10-24 Merck Patent Gmbh Viscosity reduction of highly concentrated protein formulations
CN110327292A (zh) * 2019-08-11 2019-10-15 天津乾丰瑞科技有限公司 一种盐酸法舒地尔注射制剂及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754523A (fr) * 1969-08-06 1971-02-08 Beecham Group Ltd Vaccins
SE445971B (sv) * 1978-07-04 1986-08-04 Nyegaard & Co As Forfarande for framstellning av injicerbart rontgenkontrastmedel samt en losning av nemnda medel
WO1982003773A1 (en) * 1981-04-27 1982-11-11 Baxter Travenol Lab Dialysis solution containing glucose,amino acids & insulin
DE3586844T2 (de) * 1984-06-22 1994-03-17 Richard L Veech Elektrolytlösungen und deren (in vivo) verwendung.
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
ATE111585T1 (de) 1990-01-18 1994-09-15 Cereria Amos Sgarbi Spa Grablicht.
GB9020091D0 (en) * 1990-09-14 1990-10-24 Nycomed As Contrast media
DE4135193C1 (hu) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
IT1256248B (it) * 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
WO1995026331A1 (es) * 1994-03-25 1995-10-05 Centro Investigacion Justesa Imagen, S.A. Nuevos dimeros iodados no ionicos como agentes de contraste a los rayos x, metodo para su preparacion y composiciones farmaceuticas que los contienen
DE4446694A1 (de) * 1994-12-09 1996-06-13 Schering Ag Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung

Also Published As

Publication number Publication date
NO983438D0 (no) 1998-07-24
HUP9901355A2 (hu) 1999-08-30
CN1209751A (zh) 1999-03-03
AU2150497A (en) 1997-08-20
PT876140E (pt) 2004-02-27
CA2244209C (en) 2007-10-23
EP0876140B1 (de) 2003-10-15
CA2244209A1 (en) 1997-07-31
KR19990081979A (ko) 1999-11-15
DE19703816A1 (de) 1997-08-07
ES2208884T3 (es) 2004-06-16
BG62913B1 (bg) 2000-11-30
KR100505772B1 (ko) 2005-10-25
EP0876140A2 (de) 1998-11-11
WO1997026862A3 (de) 1997-10-23
NO983438L (no) 1998-09-18
BR9707081A (pt) 1999-05-25
SK101398A3 (en) 1998-12-02
WO1997026862A2 (de) 1997-07-31
DE59710863D1 (de) 2003-11-20
US6638913B1 (en) 2003-10-28
DK0876140T3 (da) 2003-12-15
ATE251893T1 (de) 2003-11-15
PL328199A1 (en) 1999-01-18
IL124676A0 (en) 1998-12-06
JP2000505789A (ja) 2000-05-16
BG102644A (en) 1999-06-30
CZ234898A3 (cs) 1998-11-11

Similar Documents

Publication Publication Date Title
HUP9901355A3 (en) For using amino acids and - compounds for additives of x-ray contrast matter solucions, and making drugs and diagnostics
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
HUP0001811A3 (en) Bone paste and method for preparation thereof
IL128118A0 (en) Modified amino acids medicaments containing these compounds and processes for their preparation
AU5922198A (en) Dental scanning method and apparatus
IL132176A0 (en) Method for oral delivery of proteins
AU9593998A (en) Surgical probe apparatus and system
AP9901444A0 (en) Erythrommycins and process for their preparation
AU1810200A (en) Method and apparatus for providing high contrast imaging
HUP0203374A3 (en) Sold oral pharmaceutical composition and process for its preparation
AU1713195A (en) Bone cement mixing apparatus
IL130268A0 (en) Apparatus and method for visualizing ultrasonic images
HK1034906A1 (en) Method and composition of an oral preparation of itraconazole.
IL125622A0 (en) Novel erythromycin derivatives method for preparing same and use thereof as drugs
EP0821913A4 (en) METHOD AND OSTEOPOROSIS DIAGNOSTIC DEVICE
GB9800813D0 (en) Improved ultrasound contrast imaging method and apparatus
AU7249898A (en) Absorbant animal bedding and method and apparatus for making same
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
ZA97250B (en) Apparatus and method for the diagnosis of true labor
HK1015274A1 (en) Use of basic amino acids and derivatives for lowering ceramide levels.
IL125382A0 (en) High resolution imaging system and method of imaging using the same
AU7395096A (en) Method for facilitating dental diagnosis and treatment
AU1563800A (en) Method and apparatus for tissue imaging
HUT75112A (en) Oxathiolanes, method for their preparation and pharmaceutical compositions contating same
EP0970065A4 (en) ANTIBIOTICS AND THEIR PREPARATION PROCESS

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees